Prostate cancer study backs primary cryoablation
This article was originally published in Clinica
Executive Summary
Endocare has reported that as much as seven years worth of follow-up data from a 590-patient study has shown that cryoablation can be as good as or better than brachytherapy as a first-line treatment for prostate cancer.